Market data

Select a section

Ovoca Bio (CDI)

(OVB)
Sector: Pharmaceuticals & Biotechnology
1.65p
-0.05p -2.94
Last updated: 11:00:11

Company News Headlines

Date Time Headline Source
18/11/2024 07:00 Notice of AGM RNS
11/10/2024 17:30 Holding(s) in Company RNS
09/10/2024 17:45 Sale of Treasury Shares RNS
25/09/2024 07:00 Half-year Report RNS
02/09/2024 14:30 Consultancy Agreement RNS
15/07/2024 07:00 Director/PDMR Shareholding RNS
15/07/2024 07:00 Directorate Change RNS
28/06/2024 07:00 Annual Financial Report RNS
23/01/2024 07:00 Holding(s) in Company RNS
01/12/2023 12:00 Result of AGM RNS
07/11/2023 09:15 Notice of AGM RNS
28/09/2023 07:00 Interim Results RNS
31/08/2023 07:00 Summary Results of Phase II Study for Orenetide RNS
30/06/2023 07:00 Annual Financial Report RNS
12/06/2023 07:00 Update on Completion Timelines for Phase II Study RNS
16/03/2023 16:35 Price Monitoring Extension RNS
16/03/2023 14:05 Second Price Monitoring Extn RNS
16/03/2023 14:00 Price Monitoring Extension RNS
16/03/2023 09:05 Second Price Monitoring Extn RNS
16/03/2023 09:00 Price Monitoring Extension RNS
08/03/2023 07:00 Disposal of Russian Assets RNS
14/02/2023 16:41 Second Price Monitoring Extn RNS
14/02/2023 16:35 Price Monitoring Extension RNS
14/02/2023 14:05 Second Price Monitoring Extn RNS
14/02/2023 14:00 Price Monitoring Extension RNS
13/02/2023 09:00 Price Monitoring Extension RNS
13/01/2023 11:05 Second Price Monitoring Extn RNS
13/01/2023 11:00 Price Monitoring Extension RNS
28/10/2022 07:00 Result of AGM RNS
06/10/2022 14:30 Notice of AGM RNS
30/09/2022 07:00 Interim Results RNS
29/07/2022 07:00 Completion of Enrollment in Phase II Study RNS
30/06/2022 07:00 Annual Financial Report RNS
07/03/2022 09:00 Statement re Russian Business Operations RNS
23/02/2022 16:41 Second Price Monitoring Extn RNS
23/02/2022 16:36 Price Monitoring Extension RNS
22/02/2022 15:30 Russian Marketing Authorisation for Orenetide RNS
31/01/2022 07:00 Board Changes and Update RNS
30/12/2021 07:00 Directorate Change RNS
04/11/2021 15:53 Holding(s) in Company RNS
04/11/2021 15:50 Director/PDMR Shareholding RNS
04/11/2021 15:46 Board Change RNS
14/09/2021 07:00 Interim Results RNS
29/07/2021 17:00 Result of AGM RNS
24/06/2021 07:00 Annual Report and Notice of AGM RNS
10/03/2021 07:00 Migration of Participating Securities RNS
16/02/2021 14:00 Result of EGM RNS
29/01/2021 07:00 First Patient Enrolled in Phase II Study - BP-101 RNS
25/01/2021 15:30 Notice of EGM RNS
05/01/2021 07:00 Re-Filing of Marketing Authorisation Application RNS

Market data

Select a section